This course has expired. View available courses.
Neurology
Migraine prevention in general practice – ACRRM
An estimated 4.9 million Australians experience migraine causing significant pain, suffering and loss of wellbeing. Globally, migraine is the sixth highest cause of disability, and the third highest for people aged <50 years. Preventive treatments play an important role in the management of migraine for a proportion of those affected. The new CGRP inhibitor class was specifically developed for the treatment of migraine and overcomes many limitations of previous preventive therapies, thereby providing an opportunity for GPs to improve outcomes in patients with migraine.
This 1-hour accredited activity aims to empower GPs to diagnose and adopt best practice management of migraines to improve quality of life and functional outcomes for patients. It features two cases studies and expert video interviews from the faculty.
This program is supported by an independent educational grant provided by Eli Lilly.
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
1
ACCREDITATION
ACRRM
EXPIRY DATE
2022-12-31
An estimated 4.9 million Australians experience migraine causing significant pain, suffering and loss of wellbeing. Globally, migraine is the sixth highest cause of disability, and the third highest for people aged <50 years. Preventive treatments play an important role in the management of migraine for a proportion of those affected. The new CGRP inhibitor class was specifically developed for the treatment of migraine and overcomes many limitations of previous preventive therapies, thereby providing an opportunity for GPs to improve outcomes in patients with migraine.
This 1-hour accredited activity aims to empower GPs to diagnose and adopt best practice management of migraines to improve quality of life and functional outcomes for patients. It features two cases studies and expert video interviews from the faculty.
This program is supported by an independent educational grant provided by Eli Lilly.
Faculty
A/Prof Richard Stark,
AM, MB, BS, FRACP Neurologist
Simon Cowap, GP
Learning objectives
On completion of this program, GPs will be better able to:
- Define migraine as a neurological disorder and understand its clinical phases
- Recognise the burden of migraine including its significant impact on quality of life
- Demonstrate how the introduction of CGRP inhibitors has changed the treatment paradigm in migraine prevention
- Identify patients who could benefit from timely introduction of preventive therapy, including CGRP inhibitors
- Confidently initiate preventative treatments as an effective strategy in migraine management
- Develop strategies for ensuring optimal outcomes with preventive therapy including monitoring, counseling patients on administration and adherence, and providing self-care advice
Accreditation
This PDP Activity is accredited by The Australian College of Rural & Remote Medicine for 1 hour of Educational Activity.
Activity no. 25009
#
of credits: 1
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
1 hr
Duration
Physician
Profession
1
# of credits
Learning Objectives
On completion of this program, GPs will be better able to:
- Define migraine as a neurological disorder and understand its clinical phases
- Recognise the burden of migraine including its significant impact on quality of life
- Demonstrate how the introduction of CGRP inhibitors has changed the treatment paradigm in migraine prevention
- Identify patients who could benefit from timely introduction of preventive therapy, including CGRP inhibitors
- Confidently initiate preventative treatments as an effective strategy in migraine management
- Develop strategies for ensuring optimal outcomes with preventive therapy including monitoring, counseling patients on administration and adherence, and providing self-care advice
ACRRM
ACCREDITATION
Neurology
Learning Category
Medication
Topic
0
Price
2022-12-31
Expiry Date
AUS
Region/Language
Course Description
An estimated 4.9 million Australians experience migraine causing significant pain, suffering and loss of wellbeing. Globally, migraine is the sixth highest cause of disability, and the third highest for people aged <50 years. Preventive treatments play an important role in the management of migraine for a proportion of those affected. The new CGRP inhibitor class was specifically developed for the treatment of migraine and overcomes many limitations of previous preventive therapies, thereby providing an opportunity for GPs to improve outcomes in patients with migraine.
This 1-hour accredited activity aims to empower GPs to diagnose and adopt best practice management of migraines to improve quality of life and functional outcomes for patients. It features two cases studies and expert video interviews from the faculty.
This program is supported by an independent educational grant provided by Eli Lilly.
Faculty
A/Prof Richard Stark,
AM, MB, BS, FRACP Neurologist
Simon Cowap, GP
Accreditation
This PDP Activity is accredited by The Australian College of Rural & Remote Medicine for 1 hour of Educational Activity.
Activity no. 25009
1 hr
Duration
0
Price
1
# of credits
